Pureum Lee

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

A consensus HA DNA vaccine targeting clade 2.3.4.4 H5Nx influenza viruses provides broad cross-clade protection in mice and ferrets.

A consensus HA DNA vaccine targeting clade 2.3.4.4 H5Nx influenza viruses provides broad cross-clade protection in mice and ferrets.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 31, 2025

Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models.

Coronavirus nucleocapsid-based vaccine provides partial protection against hetero-species coronavirus in murine models.

Journal: Antiviral research
Published: May 31, 2024

Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model.

Pre-existing Immunity to Endemic Human Coronaviruses Does Not Affect the Immune Response to SARS-CoV-2 Spike in a Murine Vaccination Model.

Journal: Immune network
Published: September 30, 2022

Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating Toll-like receptor 4 and the NLRP3 inflammasome.

Extracellular nucleoprotein exacerbates influenza virus pathogenesis by activating Toll-like receptor 4 and the NLRP3 inflammasome.

Journal: Cellular & molecular immunology
Published: October 01, 2021

Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.

Inhibition of O-GlcNAcylation protects from Shiga toxin-mediated cell injury and lethality in host.

Journal: EMBO molecular medicine
Published: June 09, 2021

Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages.

Current Status of COVID-19 Vaccine Development: Focusing on Antigen Design and Clinical Trials on Later Stages.

Journal: Immune network
Published: January 11, 2021

Pretreatment of outer membrane vesicle and subsequent infection with influenza virus induces a long-lasting adaptive immune response against broad subtypes of influenza virus.

Pretreatment of outer membrane vesicle and subsequent infection with influenza virus induces a long-lasting adaptive immune response against broad subtypes of influenza virus.

Journal: Microbes and infection
Published: August 24, 2020

Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19.

Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19.

Journal: Immune network
Published: May 28, 2020

Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.

Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells.

Journal: Cellular microbiology
Published: March 22, 2020

Outer membrane vesicle increases the efficacy of an influenza vaccine in a diet-induced obese mouse model.

Outer membrane vesicle increases the efficacy of an influenza vaccine in a diet-induced obese mouse model.

Journal: Immunology letters
Published: September 27, 2018

Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

Bacterial Outer Membrane Vesicles Provide Broad-Spectrum Protection against Influenza Virus Infection via Recruitment and Activation of Macrophages.

Journal: Journal of innate immunity
Published: May 16, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026